IA
SRRA

IFP Advisors’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

IFP Advisors’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-6
Closed -$4K – 3667
2015
Q4 		$4K Buy
+6
New +$4.06K ﹤0.01% 3119

Other funds holding SRRA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

IFP Advisors's SRRA Position: Q1 2016 in Review

IFP Advisors sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q1 2016, closing a stake of 6 shares — an estimated $4K sold.

IFP Advisors first reported a position in SRRA in Q4 2015 and held it in 1 quarter. The position peaked at $4K in Q4 2015. 50 funds tracked by Wall St. Rank hold SRRA as of Q1 2016.

  • IFP Advisors reported no remaining Sierra Oncology, Inc. Common Stock position as of Q1 2016 after selling out during the quarter.
  • IFP Advisors sold 6 Sierra Oncology, Inc. Common Stock shares in Q1 2016, an estimated $4K.
  • IFP Advisors first reported a position in Sierra Oncology, Inc. Common Stock in Q4 2015 and held it in 1 quarter.
  • IFP Advisors's Sierra Oncology, Inc. Common Stock position peaked at $4K in Q4 2015.
  • 50 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q1 2016.

Based on IFP Advisors's 13F filing for Q1 2016, filed 2 May 2016.